Our Vision
To set the benchmark for world-class longevity and executive wellness in the UK, delivering measurable healthspan improvement through unmatched clinical excellence, personalisation, and advanced technology.
At Clino, we are at the forefront of the longevity medicine revolution, pioneering comprehensive, doctor-led, and science-backed health screening in Manchester and throughout Northwest England. As we continue to grow and shape the future of preventative healthcare, we remain open to dialogue with like-minded partners and forward-thinking organisations seeking shared value, innovation, and market-leading standards.
What We’re Open To: While Clino is not actively seeking external investors at this time, we are receptive to:
- Strategic Partnerships: Collaborations with medical, wellness, corporate, technology, and research organisations to expand our offering, enhance service delivery, or open new markets.
- Corporate Partnerships: Exploring bespoke wellness programmes for company employees and leadership teams.
- Business Opportunities: Conversations regarding franchising, joint ventures, or innovative business models that align with our values and standards.
- Medical Innovation & Research: Alliances with universities, technology platforms, or pharmaceutical innovators interested in advancing longevity science and preventative healthcare.
Why Engage with Clino?
- Unique Market Position: Serving a rapidly growing demand among high-net-worth individuals, senior professionals, and forward-thinking companies eager for medical excellence and preventive health innovation.
- Doctor-Led and Data-Driven: Our expert clinical team and investment in leading diagnostics and digital platforms ensure clinical standards, scalability, and trust.
- Brand Credibility: As early leaders in a burgeoning UK longevity sector, Clino’s name is synonymous with patient-centred, precision medicine and premium service.
Let’s Start a Conversation
If you represent a business, medical institution, corporate wellness provider, technology platform, or investment group and are interested in partnership, collaboration, or exploring mutually beneficial business initiatives, we welcome confidential initial discussions.
